Anthem (NASDAQ:ANTX) Director Sells $212,766.02 in Stock

Anthem, Inc. (NASDAQ:ANTX) Director Robin Shane Readnour sold 35,402 shares of Anthem stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $6.01, for a total value of $212,766.02. Following the sale, the director directly owned 565,592 shares in the company, valued at $3,399,207.92. The trade was a 5.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Anthem Stock Performance

Shares of ANTX stock traded down $0.01 during trading hours on Wednesday, hitting $5.96. The company had a trading volume of 266,091 shares, compared to its average volume of 711,744. Anthem, Inc. has a 12 month low of $1.00 and a 12 month high of $7.19. The firm’s fifty day moving average is $5.08 and its 200 day moving average is $3.92. The firm has a market capitalization of $224.93 million, a price-to-earnings ratio of -5.57 and a beta of -0.99.

Anthem (NASDAQ:ANTX) last posted its earnings results on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Analyst Upgrades and Downgrades

ANTX has been the topic of several recent analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Anthem in a research note on Monday, July 6th. Guggenheim began coverage on shares of Anthem in a report on Monday, July 20th. They set a “buy” rating and a $9.00 price target for the company. Leerink Partners upgraded shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price target on the stock in a research report on Thursday, May 14th. Finally, Wall Street Zen raised shares of Anthem from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $9.00.

Hedge Funds Weigh In On Anthem

A number of institutional investors and hedge funds have recently bought and sold shares of ANTX. Vivo Capital LLC acquired a new stake in shares of Anthem in the first quarter valued at $10,785,000. Commodore Capital LP acquired a new position in Anthem during the 1st quarter worth about $7,981,000. Spruce Street Capital LP bought a new stake in Anthem during the 1st quarter worth about $5,576,000. Ally Bridge Group NY LLC bought a new stake in Anthem during the 1st quarter worth about $1,800,000. Finally, Seven Fleet Capital Management LP acquired a new stake in Anthem in the 1st quarter valued at about $683,000. Institutional investors and hedge funds own 90.47% of the company’s stock.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.